April 13, 2020 -- Eurofins Discovery has announced that it aims to accelerate COVID-19 antiviral drug discovery research.
Researchers are exploring treatment strategies for the disease that include targeting angiotensin-converting enzyme 2 (ACE2), transmembrane protease serine 2 (TMPRSS2), and the SARS-CoV-2 main protease, as well as large molecule therapies, the company said.
Eurofins Discovery offers these researchers the following services: